A study for a 81 year old woman who takes Amoxicillin, Carbidopa; Levodopa (an AI-powered real world drug study)

Summary:

0 female aged 81 (±5) who take the same drugs and has adverse effects is studied. This is a phase IV clinical study for a 81 year old female patient who has Uti - Acute, Parkinson's Disease. The study is created by eHealthMe based on reports from sources including the FDA.


On Aug, 11, 2026

0 female aged 81 (±5) who take Amoxicillin, Carbidopa; Levodopa and has adverse effects is studied.


Number of reports submitted per year:

Amoxicillin, Carbidopa; Levodopa for a 81-year old woman.

Information of the patient in this study:

  • Age: 81
  • Gender: female

What are the drugs?

What are the conditions?

What are the adverse effects?


Comparison with patient's specific adverse outcomes:

You can check what is more associated with an adverse outcome: a drug mix, a drug, a condition, or a population of certain gender and age. Each patient is different. It is not uncommon that the results can be inconclusive or insignificant.

By the same drug(s):

  • Uti (urinary tract infection):
    - among females aged 81 (±5) who take the same drugs: 0% (0 of 0)
    - among people who take the same drugs, regardless of gender or age: 0% (0 of 0)
  • Parkinson's Disease:
    - among females aged 81 (±5) who take the same drugs: 0% (0 of 0)
    - among people who take the same drugs, regardless of gender or age: 0% (0 of 0)

By each condition:

  • people who have Parkinson's Disease with Uti - Acute:
    - among females aged 81 (±5) who have Uti - Acute: 0% (0 of 0)
    - among people who have Uti - Acute, regardless of gender or age: 0% (0 of 0)
  • people who have Uti with Uti - Acute:
    - among females aged 81 (±5) who have Uti - Acute: 0% (0 of 0)
    - among people who have Uti - Acute, regardless of gender or age: 0% (0 of 0)
  • people who have Uti with Parkinson's Disease:
    - among females aged 81 (±5) who have Parkinson's Disease: 4.73% (558 of 11,806)
    - among people who have Parkinson's Disease, regardless of gender or age: 3.27% (4,151 of 126,980)

By each drug (FDA data only):

  • people who take Amoxicillin and have Parkinson's Disease:
    - among females aged 81 (±5) who take Amoxicillin and have side effects: 0.02% (1 of 4,307)
    - among people who take Amoxicillin and have side effects, regardless of gender or age: 0.19% (178 of 95,856)
  • people who take Carbidopa; Levodopa and have Parkinson's Disease:
    - among females aged 81 (±5) who take Carbidopa; Levodopa and have side effects: 0% (0 of 0)
    - among people who take Carbidopa; Levodopa and have side effects, regardless of gender or age: 0% (0 of 0)
  • people who take Amoxicillin and have Uti:
    - among females aged 81 (±5) who take Amoxicillin and have side effects: 4.25% (183 of 4,307)
    - among people who take Amoxicillin and have side effects, regardless of gender or age: 2.14% (2,051 of 95,856)
  • people who take Carbidopa; Levodopa and have Uti:
    - among females aged 81 (±5) who take Carbidopa; Levodopa and have side effects: 0% (0 of 0)
    - among people who take Carbidopa; Levodopa and have side effects, regardless of gender or age: 0% (0 of 0)

Drug effectiveness *:

Amoxicillin:

n/a

Carbidopa; Levodopa:

n/a

* Some reports may have incomplete information.


How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drug side effects in long term, by gender and age:

Treatments, associated medications and conditions:

Drug side effects:

Drug interactions:

Symptoms:

Drugs that are associated with:

Conditions that are associated with:

How the phase IV clinical study uses the data?

The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: